Finepoint Capital LP Diversified Active

Location: Boston, MA

CIK: 0001608126 · Show all filings

Period: Q2 2024 (← Previous) (Next →)

Filing Date: Aug 13, 2024

Total Value: $352M (100.0% shares, 0.0% debt)

Holdings (25)

LBRDK LIBERTY BROADBAND CORP 31.0%

Value $109M Shares 1,994,510 Est. Cost $62.73 Unrealized -22.9%

RVMD REVOLUTION MEDICINES INC 8.0%

Value $28.31M Shares 729,464 Est. Cost $28.74 Unrealized +30.0%

ASND ASCENDIS PHARMA A/S 7.3%

Value $25.81M Shares 189,272 Est. Cost $102.78 Unrealized —

— SPRINGWORKS THERAPEUTICS INC 6.8%

Value $24.05M Shares 638,352 Est. Cost $29.19 Unrealized —

ARGX ARGENX SE 6.6%

Value $23.23M Shares 54,028 Est. Cost $396.43 Unrealized —

SRPT SAREPTA THERAPEUTICS INC 6.0%

Value $20.99M Shares 132,835 Est. Cost $116.29 Unrealized +10.5%

MLTX MOONLAKE IMMUNOTHERAPEUTICS 4.9%

Value $17.1M Shares 388,835 Est. Cost $43.28 Unrealized -2.1%

ARVN ARVINAS INC 4.3%

Value $15.29M Shares 574,378 Est. Cost $41.50 Unrealized -23.2%

ACAD ACADIA PHARMACEUTICALS INC 4.2%

Value $14.71M Shares 905,384 Est. Cost $19.57 Unrealized -17.5%

TVTX TRAVERE THERAPEUTICS INC 4.1%

Value $14.6M Shares 1,776,728 Est. Cost $15.68 Unrealized -57.1%

CYTK CYTOKINETICS INC 3.9%

Value $13.89M Shares 256,449 Est. Cost $40.89 Unrealized +47.6%

GLPG GALAPAGOS NV 3.8%

Value $13.45M Shares 542,762 Est. Cost $45.14 Unrealized —

RLAY RELAY THERAPEUTICS INC 3.0%

Value $10.47M Shares 1,605,346 Est. Cost $13.30 Unrealized -48.6%

PRTA PROTHENA CORP PLC 2.5%

Value $8.947M Shares 433,471 Est. Cost $32.58 Unrealized -33.6%

EYPT EYEPOINT PHARMACEUTICALS INC 1.7%

Value $6.154M Shares 707,404 Est. Cost $23.98 Unrealized -41.8%

SLDB SOLID BIOSCIENCES INC 1.5%

Value $5.45M Shares 961,251 Est. Cost $5.95 Unrealized +50.6%

— CHURCHILL CAPITAL CORP VII 0.1%

Value $192K Shares 548,000 Est. Cost $0.92 Unrealized —

MNYWW MONEYHERO LIMITED 0.0%

Value $71,600 Shares 895,000 Est. Cost $0.12 Unrealized —

CNDAW CONCORD ACQUISITION CORP II 0.0%

Value $44,917 Shares 408,333 Est. Cost $0.95 Unrealized —

IVCPW SWIFTMERGE ACQUISITION CORP 0.0%

Value $39,200 Shares 490,000 Est. Cost $0.21 Unrealized —

LSBWF LAKESHORE BIOPHARMA CO LTD 0.0%

Value $33,369 Shares 489,999 Est. Cost $0.16 Unrealized —

CLDWW CALIDI BIOTHERAPEUTICS INC 0.0%

Value $27,584 Shares 655,200 Est. Cost $0.50 Unrealized —

CDAWF COMPASS DIGITAL ACQUISITION CORP 0.0%

Value $27,548 Shares 459,906 Est. Cost $0.76 Unrealized —

— MARBLEGATE ACQUISITION CORP 0.0%

Value $26,828 Shares 735,000 Est. Cost $0.50 Unrealized —

— CALIDI BIOTHERAPEUTICS INC 0.0%

Value $25,000 Shares 125,000 Est. Cost $3.33 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
LBRDK	LIBERTY BROADBAND CORP	1,994,510	$109M	31.0%	$62.73	-22.9%	COM SER C	530307305
RVMD	REVOLUTION MEDICINES INC	729,464	$28.31M	8.0%	$28.74	+30.0%	COM	76155X100
ASND	ASCENDIS PHARMA A/S	189,272	$25.81M	7.3%	$102.78	—	SPONSORED ADR	04351P101
—	SPRINGWORKS THERAPEUTICS INC	638,352	$24.05M	6.8%	$29.19	—	COM	85205L107
ARGX	ARGENX SE	54,028	$23.23M	6.6%	$396.43	—	SPONSORED ADR	04016X101
SRPT	SAREPTA THERAPEUTICS INC	132,835	$20.99M	6.0%	$116.29	+10.5%	COM	803607100
MLTX	MOONLAKE IMMUNOTHERAPEUTICS	388,835	$17.1M	4.9%	$43.28	-2.1%	CLASS A ORD	61559X104
ARVN	ARVINAS INC	574,378	$15.29M	4.3%	$41.50	-23.2%	COM	04335A105
ACAD	ACADIA PHARMACEUTICALS INC	905,384	$14.71M	4.2%	$19.57	-17.5%	COM	004225108
TVTX	TRAVERE THERAPEUTICS INC	1,776,728	$14.6M	4.1%	$15.68	-57.1%	COM	89422G107
CYTK	CYTOKINETICS INC	256,449	$13.89M	3.9%	$40.89	+47.6%	COM NEW	23282W605
GLPG	GALAPAGOS NV	542,762	$13.45M	3.8%	$45.14	—	SPON ADR	36315X101
RLAY	RELAY THERAPEUTICS INC	1,605,346	$10.47M	3.0%	$13.30	-48.6%	COM	75943R102
PRTA	PROTHENA CORP PLC	433,471	$8.947M	2.5%	$32.58	-33.6%	SHS	G72800108
EYPT	EYEPOINT PHARMACEUTICALS INC	707,404	$6.154M	1.7%	$23.98	-41.8%	COM NEW	30233G209
SLDB	SOLID BIOSCIENCES INC	961,251	$5.45M	1.5%	$5.95	+50.6%	COM NEW	83422E204
—	CHURCHILL CAPITAL CORP VII	548,000	$192K	0.1%	$0.92	—	*W EXP 02/29/202	17144M110
MNYWW	MONEYHERO LIMITED	895,000	$71,600	0.0%	$0.12	—	*W EXP 09/13/202	G6202B119
CNDAW	CONCORD ACQUISITION CORP II	408,333	$44,917	0.0%	$0.95	—	*W EXP 99/99/999	20607U116
IVCPW	SWIFTMERGE ACQUISITION CORP	490,000	$39,200	0.0%	$0.21	—	*W EXP 12/13/202	G63836111
LSBWF	LAKESHORE BIOPHARMA CO LTD	489,999	$33,369	0.0%	$0.16	—	*W EXP 03/15/202	G9845F117
CLDWW	CALIDI BIOTHERAPEUTICS INC	655,200	$27,584	0.0%	$0.50	—	*W EXP 03/14/202	320703119
CDAWF	COMPASS DIGITAL ACQUISITION CORP	459,906	$27,548	0.0%	$0.76	—	*W EXP 09/29/202	G2476C123
—	MARBLEGATE ACQUISITION CORP	735,000	$26,828	0.0%	$0.50	—	*W EXP 08/31/202	56608A113
—	CALIDI BIOTHERAPEUTICS INC	125,000	$25,000	0.0%	$3.33	—	COM NEW	320703101